(Q46731862)

English

Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Jean-Claude Forest

5

object named as

Forest JC

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

author name string

Lemay A

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

Dodin S

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

Turcot L

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

Déchêne F

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

language of work or name

0 references

publication date

30 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

Human Reproduction

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

21

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

121-128

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

Ultrasound assessment of the polycystic ovary: international consensus definitions.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected].

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Low-dose oral contraceptives and carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Estrogen/progesterone replacement versus pravastatin and their sequential association in hypercholesterolemic postmenopausal women

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI312

21 January 2018

Identifiers

10.1093/HUMREP/DEI312

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199428

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46731862&oldid=2128974276"